Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Balzarotti

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-escalation of CHOP in non-Hodgkin's lymphomaA Santoro, M Balzarotti, C Tondini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized studyC Tondini, M Balzarotti, I Rampinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVDV Bonfante, A Santoro, S Viviani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Initial chemotherapy for primary resectable large-cell lymphoma of the stomachC Tondini, M Balzarotti, A Santoro, et al.
Bone Marrow Transplantation|December 26, 2001
Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphomaM Magagnoli, B Sarina, M Balzarotti, et al.
British Journal of Cancer|April 7, 1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implicationsS Viviani, E Camerini, V Bonfante, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experienceC Tondini, R Giardini, F Bozzetti, et al.
Seminars in Oncology|May 29, 1999
Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostineM Balzarotti, S Grisanti, K Granzow, et al.
Bone Marrow Transplantation|October 2, 2007
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patientsM Magagnoli, M Spina, M Balzarotti, et al.
Bone Marrow Transplantation|August 31, 2002
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomasL Castagna, A Bertuzzi, A Nozza, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-escalation of CHOP in non-Hodgkin's lymphomaA Santoro, M Balzarotti, C Tondini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized studyC Tondini, M Balzarotti, I Rampinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVDV Bonfante, A Santoro, S Viviani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Initial chemotherapy for primary resectable large-cell lymphoma of the stomachC Tondini, M Balzarotti, A Santoro, et al.
Bone Marrow Transplantation|December 26, 2001
Mobilizing potential of ifosfamide/vinorelbine-based chemotherapy in pretreated malignant lymphomaM Magagnoli, B Sarina, M Balzarotti, et al.
British Journal of Cancer|April 7, 1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implicationsS Viviani, E Camerini, V Bonfante, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
Combined modality treatment for primary gastrointestinal non-Hodgkin's lymphoma: the Milan Cancer Institute experienceC Tondini, R Giardini, F Bozzetti, et al.
Seminars in Oncology|May 29, 1999
Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostineM Balzarotti, S Grisanti, K Granzow, et al.
Bone Marrow Transplantation|October 2, 2007
IGEV regimen and a fixed dose of lenograstim: an effective mobilization regimen in pretreated Hodgkin's lymphoma patientsM Magagnoli, M Spina, M Balzarotti, et al.
Bone Marrow Transplantation|August 31, 2002
Reduced intensity conditioning regimen followed by glycosylated G-CSF mobilized PBSCT in patients with solid tumors and malignant lymphomasL Castagna, A Bertuzzi, A Nozza, et al.
Pageof 3